Form 4 for SER Serina Therapeutics, Inc.
Accepted 2025-08-20 00:00:00 ET · period of report 2025-08-18 · accession 0001708599-25-000097 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-08-20 | 2025-08-18+ | SER | Moreadith Randall | CSO | M - OptEx | $0.06 | +4,304 | 2,077 | New | +$258.24 |
| DM | 2025-08-20 | 2025-08-18+ | SER | Moreadith Randall | CSO | S - Sale+OE | $5.18 | -4,304 | 0 | -100% | -$22.3K |
| DM | 2025-08-20 | 2025-08-18+ | SER | Moreadith Randall | CSO | M - OptEx | $0.00 | -4,304 | 469.2K | -0.9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-18 | M | A | 2,227 | $0.06 | 2,227 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-20 | S | D | 2,077 | $5.10 | 0 | D | — | — | |
| 3 | Common | Common Stock | 2025-08-20 | M | A | 2,077 | $0.06 | 2,077 | D | — | — | |
| 4 | Common | Common Stock | 2025-08-18 | S | D | 2,227 | $5.25 | 0 | D | — | — | |
| 5 | Derivative | Stock Option (right to buy) | 2025-08-18 | M | D | 2,227 | $0.00 | 471,263 | D | $0.06 · — to 2031-05-06 | 2,227 Common Stock | (F1) The stock options are fully vested. |
| 6 | Derivative | Stock Option (right to buy) | 2025-08-20 | M | D | 2,077 | $0.00 | 469,186 | D | $0.06 · — to 2031-05-06 | 2,077 Common Stock | (F1) The stock options are fully vested. |